SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is trending with significant community excitement, fueled by its multichain presence across Solana, Cronos, and Ethereum, and its deflationary bridge-burn mechanism. Enthusiasts are actively touting it as a unique meme coin with organic growth and a strong foundation. The conversation highlights its potential to capture wider attention and volume within the evolving crypto landscape.

America's Oil Reserve for the Digital Age

U.S Oil

The USOR crypto token is trending due to significant community speculation around an anticipated event in early February, driving hopes for substantial gains. However, a strong counter-narrative exists, with many users warning of potential scam characteristics and concerns about a "rug pull" for this Solana-based meme coin, while others are actively seeking information on where to acquire it.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. (BNAI) is experiencing a dramatic short squeeze, driven by a recent deal and debt-for-equity conversion, despite underlying fundamental concerns. The community is actively discussing the stock's explosive run, fueled by its low float and high borrow rates, drawing parallels to other historic market rallies. While many anticipate further gains and continued short pain, others caution about the sustainability of the rapid ascent.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as its community rallies around its unique identity as a 'culture coin' on the Solana blockchain, frequently drawing parallels to Bitcoin's long-term potential. Enthusiasts are focused on 'BeLeaf' in the project's enduring cultural mission, linking it to broader cannabis and hemp movements for natural medicine and sustainable agriculture. The primary talking point among holders emphasizes consistent community engagement and a long-term perspective over transient market fluctuations.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as the community keenly anticipates the upcoming release of 3-year topline data from its pivotal EMBARK study for ELEVIDYS, generating widespread speculation of positive results. Investors are actively debating the potential for a significant market reaction and a short squeeze, while also assessing the long-term value of its expanding rare disease pipeline, particularly the promising siRNA programs with Arrowhead.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is currently a hot topic due to the surging price of silver, igniting fervent community discussions about the metal's potential to reach unprecedented levels. Enthusiastic investors are highlighting recent high-grade drill results and substantial backing from key investors, anticipating exponential growth and a significant short squeeze. Despite some market skepticism regarding the valuation of a pre-production miner, many believe Hycroft is strongly positioned to capitalize on the broader appeal of precious metals.

Americas Gold & Silver Corp. engages in the acquisition, exploration, development, and exploration of mineral resource properties. It operates through the following segments: Cosalá Operations, Galena Complex, Relief Canyon, and Corporate and Other. The Cosalá Operations segment operates in Mexico. The Galena Complex and Relief Canyon segments focuses on the United States. The company was founded by Peter Jude Hawley on May 12, 1998 and is headquartered in Toronto, Canada.

Americas Gold and Silver Corp

Americas Silver Corp

Americas Gold and Silver (USAS) is trending due to its strategic focus on maximizing antimony recovery and commercialization, a critical mineral, alongside strong investor anticipation of a prolonged silver price surge. The community is keenly discussing its potential as a leading U.S. antimony producer and views the company as significantly undervalued given the expanding demand for strategic metals.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is actively discussed following promising Phase 1 data for its soquelitinib eczema treatment, alongside the closing of an upsized public offering that secured significant capital. The community is sharply divided, with bulls touting the drug's potential in a large market and the funding's strategic value, while skeptics highlight the early development stage, existing high valuation, and share dilution.

Pan American Silver Corp. engages in the operation, development, and exploration of silver and gold producing properties and assets. It operates through the Silver and Gold segments. The Silver segment includes La Colorada, Huaron, Morococha, San Vicente, and Manantial Espejo mines. The Gold segment refers to the Dolores, Shahuindo, La Arena, Timmins West, and Bell Creek mines. The company was founded by Ross J. Beaty and John H. Wright on March 7, 1979 and is headquartered in Vancouver, Canada.

Pan American Silver Corp

Pan American Silver is a major talking point following strong full-year production results, including record silver output and rising cash flow, augmented by its strategic MAG Silver acquisition. Community discussions are rife with bullish sentiment, highlighting a disconnect between physical and paper silver, and the potential for a monumental "silver squeeze" amid increasing industrial demand. This fuels expectations for significant upside in the broader precious metals sector.

BlackRock Institutional Trust Company N.A. - iShares J.P. Morgan USD Emerging Markets Bond ETF

iShares J.P. Morgan USD Emerging Markets Bond ETF

iShares J.P. Morgan USD Emerging Markets Bond ETF ($EMB) is trending, buoyed by consistent bullish momentum and positive sentiment indicators, which have propelled it to a new 52-week high. The financial community is noting its strong leadership within the fixed income sector, as emerging market sovereign bonds demonstrate resilience and appeal for diversified income generation. This performance stands out amidst a broader environment where credit-focused assets are gaining favor over traditional long-duration Treasuries.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC...

Short Interest in ADC Therapeutics SA (NYSE:ADCT) Drops By 47.2%

ADC Therapeutics SA (NYSE:ADCT - Get Free Report) saw a large decline in short interest in the month of December. As of December 31st, there was short interest totaling 3,573,570 shares, a decline of...

Are Medical Stocks Lagging  ADC Therapeutics (ADCT) This Year?

Here is how ADC Therapeutics SA (ADCT) and Agenus (AGEN) have performed compared to their sector so far this year.

ADC Therapeutics SA (NYSE:ADCT) Given Consensus Recommendation of "Moderate Buy" by Brokerages

ADC Therapeutics SA (NYSE:ADCT - Get Free Report) has earned an average rating of "Moderate Buy" from the six brokerages that are currently covering the company, Marketbeat.com reports. One...

ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates

ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025...

ADC Therapeutics Announces New Employee Inducement Grant

ADC Therapeutics Announces New Employee Inducement Grant ADC Therapeutics Announces New Employee Inducement Grant PR Newswire LAUSANNE, Switzerland, Jan. 2, 2026 LAUSANNE, Switzerland, Jan. 2, 2026...

ADC Therapeutics (ADCT) Upgraded to Buy: Here's Why

ADC Therapeutics (ADCT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.

Adc Therapeutics SA

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

ADCT
Adc Therapeutics SA

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ADCT News

ADCTAdc Therapeutics SA